Citations

Institution: Mayo Clinic Clear

Showing 10 of 108152 citations.

Transapical Myectomy for Septal Hypertrophy Not Accessible Through the Aortic Root
Quintana, Eduard , Schaff, Hartzell V. , Dearani, Joseph A.

World Journal for Pediatric and Congenital Heart Surgery | July 15, 2015 | Volume: 6 | Issue: 3 | Pages: 455-457

10.1177/2150135115589791 | PMID 26180164 Get It

Exposure of the basal and midventricular septum through the aortic root to relieve obstruction in hypertrophic cardiomyopathy can be challenging. Inadequate myectomy will lead to persistent symptoms and disability. Adequate exposure of the obstructive left ventricular septum is of paramount importance in primary and redo myectomy. In selected patients, either at primary myectomy or at redo myectomy, septal excision can be approached through a left ventricular transapical incision when transaortic exposure is inadequate.
The Value of Repeat Thyroid Fine-Needle Aspiration Biopsy in Patients with a Previously Benign Result: How Often Does It Alter Management?
Ospina, Naykky Singh , Sebo, Thomas J., Castro, M. Regina , Ospina, Naykky Singh , Singh Ospina, Naykky, Morris, John C., Singh Ospina, Naykky M , Singh Ospina, Naykky

Thyroid | July 15, 2015 | Volume: 25 | Issue: 10 | Pages: 1121-1126

10.1089/thy.2015.0146 | PMID 26177342 Get It

Impact of long‐term tenofovir disoproxil fumarate on incidence of hepatocellular carcinoma in patients with chronic hepatitis B
Kim, W. Ray , Loomba, Rohit , Schall, Raul E. Aguilar, Yee, Leland J. , Dinh, Phillip , Flaherty, John F. , Martins, Eduardo B. , Therneau, Terry M. , Jacobson, Ira M. , Fung, Scott , Gürel, Selım , Buti, Marı́a , Marcellin, Patrick , Berg, Thomas , Buti, Maria , Loomba, Rohit

Cancer | July 15, 2015 | Volume: 121 | Issue: 20 | Pages: 3631-3638

10.1002/cncr.29537 | PMID 26177866 Get It

BACKGROUNDEfficacy trials have shown that antiviral therapy improves the outcomes of patients with chronic hepatitis B virus (HBV) infection. However, prospective data regarding the effect of antiviral therapy on the incidence of hepatocellular carcinoma (HCC), especially among patients without cirrhosis, are limited. The authors examined the impact of tenofovir disoproxil fumarate (TDF) on the incidence of HCC using a validated prediction model.METHODSThe incidence of HCC in patients treated with TDF was obtained in the pivotal TDF registration studies after 384 weeks of follow‐up. The predicted risk of HCC in individual patients was calculated using the Risk Estimation for Hepatocellular Carcinoma in Chronic Hepatitis B (REACH‐B) model, which estimates HCC incidence for up to 10 years based on age, sex, alanine aminotransferase level, hepatitis B e antigen status, and HBV‐DNA. Standardized incidence ratios (SIRs) were calculated comparing the observed and predicted numbers of HCC cases in the study cohort.RESULTSAmong 634 patients with evaluable baseline biopsies, 152 had cirrhosis (Ishak fibrosis score of 5 or 6) and 482 did not. During the 384 weeks of study, 14 cases of HCC were reported, with 4 occurring within the first year. The incidence of HCC was 0.37% per year in the study as a whole (0.28% among patients without cirrhosis and 0.65% among patients with cirrhosis). Among patients without cirrhosis, the observed incidence of HCC was significantly lower than predicted (SIR, 0.40; 95% confidence interval, 0.199‐0.795). The last HCC case in a patient with cirrhosis occurred around week 192 with an SIR of 0.51 (95% confidence interval, 0.231‐1.144) reported at week 384.CONCLUSIONSBased on the REACH‐B risk calculator, long‐term therapy with TDF was associated with a reduced incidence of HCC among patients without cirrhosis who met treatment criteria. Cancer 2015;121:3631–3638. © 2015 American Cancer Society.
Low-Flow, Low-Gradient Severe Aortic Stenosis in the Setting of Constrictive Pericarditis
Tsang, Michael , Choi, Jin‐Oh , Borlaug, Barry A. , Greason, Kevin L. , Cha, Stephen S., Oh, Jae K. , Tsang, Michael Y C, Cha, Stephen S., Nishimura, Rick A. , Oh, Jae K. , Borlaug, Barry A

Circulation: Cardiovascular Imaging | July 15, 2015 | Volume: 8 | Issue: 7 | Pages: No page available

10.1161/circimaging.114.002812 | PMID 26175530 Get It

Background— Low-flow, low-gradient aortic stenosis (AS), associated with a poor prognosis, can be caused by a reduced stroke volume despite a preserved ejection fraction (left ventricular ejection fraction). We hypothesized that impaired ventricular diastolic filling secondary to constrictive pericarditis (CP) could contribute to reduced transaortic gradients in patients with AS+CP. We sought to examine the characteristics and outcomes of this unique cohort. Methods and Results— We analyzed 84 patients with different degrees of AS and preserved left ventricular ejection fraction (≥50%): 28 diagnosed with concomitant CP by echocardiography and 56 patients without CP matched by age, sex, and AS severity during 1998 to 2013. Prior mediastinal radiation (32.1% versus 5.4%; P =0.0072) and cardiac surgery (50.0% versus 3.6%; P =0.0016) were more common in AS+CP patients than those with AS only. AS+CP patients had lower left ventricular stroke volume index and mean transaortic gradients. Five-year survival was 34.3% for AS+CP patients and 89.1% for those with AS only ( P <0.001). In univariate analysis, prior mediastinal radiation (hazard ratio, 8.35; 95% confidence interval, 3.38–20.62; P <0.001), reduced left ventricular stroke volume index of <35 mL/m 2 (hazard ratio, 12.52; 95% confidence interval, 3.97–39.48; P <0.001), and concomitant CP (hazard ratio, 13.65; 95% confidence interval, 4.85–38.41; P <0.001) were highly associated with increased mortality. Conclusions— Our findings highlighted the possibility of CP as a pathophysiological mechanism for low-flow, low-gradient AS. Left ventricular stroke volume index and transaortic gradients were commonly reduced in AS in the setting of CP despite a preserved left ventricular ejection fraction, which may result in underestimation of AS severity. Prior mediastinal radiation, lower left ventricular stroke volume index, and concomitant CP were associated with poorer survival in AS patients.
Of the Importance of Motherhood and Apple Pie
Roger, Véronique L.

Circulation: Cardiovascular Quality and Outcomes | July 15, 2015 | Volume: 8 | Issue: 4 | Pages: 329-331

10.1161/circoutcomes.115.002115 | PMID 26175536 Get It

Efficacy and safety of once‐weekly glucagon‐like peptide 1 receptor agonists for the management of type 2 diabetes: a systematic review and meta‐analysis of randomized controlled trials
Karagiannis, Thomas , Liakos, Aris , Bekiari, Eleni , Athanasiadou, Eleni , Paschos, Paschalis , Vasilakou, Despoina , Mainou, Maria , Rika, Maria, Boura, Panagiota, Τσάπας, Απόστολος , Liakos, A , Tsapas, A , Matthews, David Richard , Karagiannis, Thomas , Bekiari, Eleni

Diabetes, Obesity and Metabolism | July 15, 2015 | Volume: 17 | Issue: 11 | Pages: 1065-1074

10.1111/dom.12541 | PMID 26395850 Get It

Aim To assess the efficacy and safety of recently approved once‐weekly glucagon‐like peptide 1 receptor agonists ( GLP ‐1 RAs ) in patients with type 2 diabetes. Methods We conducted a systematic review and meta‐analysis of randomized controlled trials comparing any GLP ‐1 RA licensed for once‐weekly dosing (albiglutide, dulaglutide or exenatide extended release) with placebo or other antidiabetic agents. We searched M edline, E mbase, the C ochrane L ibrary and grey literature for articles published up to D ecember 2014 and extracted data in duplicate. Results In our systematic review we included 33 trials with a total of 16 003 participants. Compared with placebo the change in glycated haemoglobin ( HbA1c ) concentration was −0.66% [six studies; 95% confidence interval ( CI ) −1.14 to −0.19; I 2 = 88%] with albiglutide, and −1.18% (seven studies; 95% CI −1.34 to −1.02; I 2 = 65%) with dulaglutide. Based on data from placebo‐controlled trials, we did not detect statistically significant weight‐sparing benefits for albiglutide or dulaglutide. Compared with other antidiabetic agents, once‐weekly GLP ‐1 RAs outperformed sitagliptin, daily exenatide and insulin glargine in terms of HbA1c ‐lowering (mean differences −0.40%; 95% CI −0.66 to −0.14; I 2 = 85%, −0.44%; 95% CI −0.58 to −0.29; I 2 = 40% and −0.28; 95% CI −0.45 to −0.10; I 2 = 81%, respectively). The main adverse effects of treatment included gastrointestinal and injection site reactions. Conclusions Given their dosing scheme and overall efficacy and safety profile, once‐weekly GLP ‐1 RAs are a convenient therapeutic option for use as add‐on to metformin.
Getting back together after a break‐up: Relationship advice for anatomists and surgeons
Phitayakorn, Roy , Lachman, Nirusha

Clinical Anatomy | July 15, 2015 | Volume: 28 | Issue: 7 | Pages: 931-934

10.1002/ca.22596 | PMID 26174432 Get It

The “surgeon‐anatomist” was originally a single individual who self‐pursued knowledge and understanding of anatomy as the foundation for successful surgical outcomes. However, recent advances in medical education have ironically led to the separation of anatomy and surgery. This physical and emotional “divorce” of anatomists and surgeons into separate individuals has created several critical educational issues for medical and surgical educators including a general lack of anatomical knowledge in medical students and misalignment of graduate medical education procedural specialty training with the Accreditation Council of Graduate Medical Education Core Competencies and now the Next Accreditation System. There are numerous opportunities for anatomists and surgeons to work together to improve educational instruction of established difficult anatomical regions, procedural training, or even develop new techniques and procedures. Similarly, anatomists with specialized training in medical education would be invaluable partners to ensure that procedural assessments align with instructional technologies for truly longitudinal curricula that starts at the medical student level, but stops at the patient outcomes of attending surgeons. This mutually beneficial relationship would be similar to multidisciplinary care teams and current surgeon and PhD/EdD partnerships. The restoration of the relationship between anatomists and surgeons would be invaluable to surgical education and remains an exciting research opportunity. Clin. Anat. 28:931–934, 2015. © 2015 Wiley Periodicals, Inc.
MRI in radiation oncology: Underserved needs
McGee, Kiaran P. , Hu, Yanle , Tryggestad, E., Brinkmann, Debra H. , Witte, Bob, Welker, Kirk M. , Panda, Anshuman , Haddock, Michael G. , Bernstein, Matt A. , Tryggestad, Erik, Brinkmann, Debra, Welker, Kirk, Haddock, Michael, Bernstein, Matt A

Magnetic Resonance in Medicine | July 14, 2015 | Volume: 75 | Issue: 1 | Pages: 11-14

10.1002/mrm.25826 | PMID 26173404 Get It

Central venous access device (CVAD) complications in Haemophilia with inhibitors undergoing immune tolerance induction: Lessons from the international immune tolerance study
Rodriguez, Vilmarie , Mancuso, Maria Elisa , Hay, C. R. M. , Valentino, Leonard A. , Warad, Deepti , DiMichele, Donna , Kenet, Gili , Kulkarni, Roshni

Haemophilia | July 14, 2015 | Volume: 21 | Issue: 5 | Pages: No page available

10.1111/hae.12740 | PMID 26178581 Get It

IntroductionCentral venous access devices (CVADs) are frequently required as stable long‐lasting venous access in children with haemophilia, especially those requiring immune tolerance induction (ITI) for inhibitors. CVAD infection is one of the most frequently reported catheter‐related complications in this patient population.AimDetailed review of CVAD complications from the International ITI (I‐ITI) study and analysis of potential risk factors for such complications.MethodsRetrospective analysis of prospectively obtained data from the I‐ITI study primarily focused on CVAD‐related complications.ResultsA total of 115 children were recruited and 183 CVADs were placed in 99 subjects resulting in 121,206 CVAD‐days observed on‐study. A total of 124 CVAD infections were reported in 41 of 99 (41%) subjects with an overall infection rate of 0.94 per 1000 CVAD‐days (interquartile ranges 0–1.7). A similar number of infections were observed in the two treatment arms (median: 2 and 3 in high dose and low dose respectively). Infections occurred more frequently in the presence of external catheters than with fully implanted catheters (P = 0.026). Infected patients were significantly younger at the time of CVAD insertion (median age: 22 vs. 25 months, P = 0.020). Patients with Gram‐positive infections were also significantly younger than those with Gram‐negative infections (median age: 17 vs. 25 months, P < 0.0001).ConclusionCVAD infection was the most common complication observed in children with severe haemophilia and inhibitors in the frame of the I‐ITI study. Younger age at CVAD insertion and external CVAD were associated with higher risk for infection. ITI outcome was unaffected by CVAD infections.
Editorial: proton pump inhibitor‐responsive oesophageal eosinophilia ‐ two different phenotypes?
Molina‐Infante, Javier , Katzka, David A.

Alimentary Pharmacology & Therapeutics | July 14, 2015 | Volume: 42 | Issue: 4 | Pages: 485-487

10.1111/apt.13278 | PMID 26179762 Get It